Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T:

Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T: Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy 1997, 43:340–345.PubMedCrossRef 4. Yokoi N, Okada K, Sugita J, Kinoshita S: Acute conjunctivitis associated with biofilm formation on a punctal plug. Jpn J Ophthalmol

2000, 44:559–560.PubMedCrossRef 5. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP: Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762–764.PubMedCrossRef 6. Christensen SK, Pedersen K, Hansen FG, Gerdes K: Toxin-antitoxin loci as stress-response elements: ChpK/MazF and ChpBK cleave translated A-1210477 cell line RNAs Selleck XAV 939 and are counteracted by tmRNA. J Mol Biol 2003, 332:809–819.PubMedCrossRef 7. Kolenbrander PE, Andersen RN, Kazmerzak KM, Palmer RJ Jr: Coaggregation and Repotrectinib chemical structure coadhesion

in oral biofilms. In Community Structure and Co-operation in biofilms. Edited by: Allison DG, Gilbert HM, Scott L, Wilson M. Cambridge University Press; 2000:65–85.CrossRef 8. O’Toole G, Kolter R: The initiation of biofilm formation in Pseudomonas aeruginosa fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998, 28:449–461.PubMedCrossRef 9. Costerton JW, Lam J, Lam K, Chan R: The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections. Rev Infect Dis 1983,5(Suppl 5):867–873.CrossRef 10. Hoiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A: Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001, 3:23–35.PubMedCrossRef 11. Lam J, Chan R, Lam K, Costerton JW: Production of mucoid microcolonies

by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980, 28:546–556.PubMed 12. Harshley RM: Bacterial motility on a surface: many ways to a common goal. Annu Rev Microbiol 2003, 57:249–273.CrossRef 13. Koch B, Jense LE, Nybroe O: A panel of Tn 7 -based vectors for insertion of the gfp marker gene or for delivery of cloned DNA into Gram-negative bacteria at a neutral chromosomal site. J Microbiol Methods 2001, 45:187–195.PubMedCrossRef 14. Lawrence JR, tuclazepam Delaquis PJ, Korber DR, Caldwell DE: Behavior of Pseudomonas fluorescens within the hydrodynamic boundary layers of surface microenvironments. Microb Ecol 1987, 14:1–4.CrossRef 15. Mahenthiralingam E, Campbell ME, Speert DP: Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonised patients with cystic fibrosis. Infect Immun 1994, 62:569–605. 16. Sauer K, Camper AK, Erlich GD, Costerton JW, Davies DG: Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002, 184:1140–1154.PubMedCrossRef 17.

Comments are closed.